Around the world, millions of people are at risk from poor-quality medicines, especially in low- and middle-income countries.1 Because these medicines may not work as expected – or even at all – they can cause treatment failure and adverse reactions, may contribute to the development of antimicrobial resistance, and even cause illness or death.
Here’s how USP, with funding from USAID and other donors, is working to help low- and middle-income countries protect people from the dangers of poor-quality medicines.
Hover over or tap on the icons below to learn more.
More patients can access quality-assured medicines to prevent or treat deadly infections like tuberculosis, malaria, and HIV when USP helps manufacturers meet international standards for good manufacturing practices.
More patients are protected when USP works with regulators to implement sustainable surveillance systems to detect and remove poor-quality medicines from the marketplace.
More patients are protected from poor-quality medicines when USP helps governments put in place national policies for quality assurance of medical products.
Fewer patients are at risk of taking substandard and falsified medicines when USP helps laboratories build capacity to detect poor-quality medicines, which can then be removed from the market.
More patients can feel confident their medicines are quality-assured when USP empowers regulatory staff with skills and procedures for improving how medicines new to the market are approved.
